Loading data
CSLNYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 5.02 bn USD | 5 bn USD | 4.59 bn USD | 5.45 bn USD | 3.84 bn USD |
| Cost of revenue | 3.23 bn USD | 3.12 bn USD | 2.95 bn USD | 3.58 bn USD | 2.74 bn USD |
| Gross profit | — | — | 1.63 bn USD | 1.87 bn USD | — |
| Research and development expense | 47.1 m USD | 35.4 m USD | 28.7 m USD | 19 m USD | 16.4 m USD |
| Selling, general and administrative expense | 745.4 m USD | 722.8 m USD | 625.2 m USD | 623.5 m USD | 507.8 m USD |
| Operating profit | 1 bn USD | 1.14 bn USD | 982.8 m USD | 1.2 bn USD | 573.4 m USD |
| Profit before tax | 948.8 m USD | 1.11 bn USD | 930.4 m USD | 1.12 bn USD | 489.9 m USD |
| Income tax expense | 206.3 m USD | 245.8 m USD | 211.5 m USD | 265.7 m USD | 104.3 m USD |
| Net income (reported basis) | 740.7 m USD | 1.31 bn USD | 767.4 m USD | 924 m USD | 421.7 m USD |
| Net income attributable to common shareholders | — | 1.31 bn USD | 765.6 m USD | 921.8 m USD | 420.5 m USD |
| Basic earnings per share | 17.27 USD/share | 28.17 USD/share | 15.35 USD/share | 17.8 USD/share | 8.01 USD/share |
| Diluted earnings per share | 17.12 USD/share | 27.82 USD/share | 15.18 USD/share | 17.56 USD/share | 7.91 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.